Asteron Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 16-12-2024
- Paid Up Capital ₹ 1.48 M
as on 16-12-2024
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 44.49%
(FY 2022)
- Profit 19.05%
(FY 2022)
- Ebitda 16.24%
(FY 2022)
- Net Worth 19.49%
(FY 2022)
- Total Assets 1.11%
(FY 2022)
About Asteron Pharmaceuticals
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 1.48 M, as per Ministry of Corporate Affairs (MCA) records.
Sandheep Pooloth and Shabith serve as directors at the Company.
- CIN/LLPIN
U51397KL2016PTC045479
- Company No.
045479
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Mar 2016
- Date of AGM
04 Oct 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thrissur, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Asteron Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandheep Pooloth  | Director | 19-Dec-2016 | Current |
| Shabith | Director | 19-Jul-2018 | Current |
Financial Performance of Asteron Pharmaceuticals.
Asteron Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 44.49% increase. The company also saw a substantial improvement in profitability, with a 19.05% increase in profit. The company's net worth Soared by an impressive increase of 19.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asteron Pharmaceuticals?
In 2017, Asteron Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Asteron Pharmaceuticals?
Unlock and access historical data on people associated with Asteron Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asteron Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asteron Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
